Marrow transplantation has generally been limited to patients with a sibling who is genotypically identical for HLA. In a study of the acceptable limits of HLA incompatibility, 105 consecutive patients with hematologic cancers who received marrow grafts from haploidentical donors (study group) were compared with 728 similar patients concurrently receiving grafts from HLA genotypically identical siblings (control group). The unshared haplotypes differed variably: 12 were phenotypically but not genotypically identical for HLA-A, HLA-B, and HLA-D; 63 differed at one locus (A, B, or D); 24 at two loci; and 6 at three. A higher proportion of study patients had delayed engraftment, granulocytopenia, or graft rejection. Acute graft versus host disease occurred earlier and with greater frequency in study patients. The risk of the disease did not correlate with disparity for Class I (A or B) versus Class II (D-region) loci. Thus, incompatibility for HLA has an important effect on the course after clinical marrow transplantation. In spite of these complications, there was no statistically significant difference in the survival of the study patients and control patients who received their transplants during remission.
This article has been cited by other articles:
Arora, M., Weisdorf, D. J., Spellman, S. R., Haagenson, M. D., Klein, J. P., Hurley, C. K., Selby, G. B., Antin, J. H., Kernan, N. A., Kollman, C., Nademanee, A., McGlave, P., Horowitz, M. M., Petersdorf, E. W.
(2009). HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia. JCO
27: 1644-1652
[Abstract][Full Text]
Wehler, T. C., Nonn, M., Brandt, B., Britten, C. M., Grone, M., Todorova, M., Link, I., Khan, S. A., Meyer, R. G., Huber, C., Hartwig, U. F., Herr, W.
(2007). Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines. Blood
109: 365-373
[Abstract][Full Text]
Lin, M.-T., Storer, B., Martin, P. J., Tseng, L.-H., Grogan, B., Chen, P.-J., Zhao, L. P., Hansen, J. A.
(2005). Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor {beta} genotype of donor. Blood
106: 3995-4001
[Abstract][Full Text]
Spitzer, T. R.
(2005). Haploidentical Stem Cell Transplantation: The Always Present but Overlooked Donor. ASH Education Book
2005: 390-395
[Abstract][Full Text]
Ichinohe, T., Uchiyama, T., Shimazaki, C., Matsuo, K., Tamaki, S., Hino, M., Watanabe, A., Hamaguchi, M., Adachi, S., Gondo, H., Uoshima, N., Yoshihara, T., Hatanaka, K., Fujii, H., Kawa, K., Kawanishi, K., Oka, K., Kimura, H., Itoh, M., Inukai, T., Maruya, E., Saji, H., Kodera, Y., for the Japanese Collaborative Study Group for NIM,
(2004). Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood
104: 3821-3828
[Abstract][Full Text]
Flomenberg, N., Baxter-Lowe, L. A., Confer, D., Fernandez-Vina, M., Filipovich, A., Horowitz, M., Hurley, C., Kollman, C., Anasetti, C., Noreen, H., Begovich, A., Hildebrand, W., Petersdorf, E., Schmeckpeper, B., Setterholm, M., Trachtenberg, E., Williams, T., Yunis, E., Weisdorf, D.
(2004). Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood
104: 1923-1930
[Abstract][Full Text]
Neudorf, S., Sanders, J., Kobrinsky, N., Alonzo, T. A., Buxton, A. B., Gold, S., Barnard, D. R., Wallace, J. D., Kalousek, D., Lange, B. J., Woods, W. G.
(2004). Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood
103: 3655-3661
[Abstract][Full Text]
Lin, M.-T., Storer, B., Martin, P. J., Tseng, L.-H., Gooley, T., Chen, P.-J., Hansen, J. A.
(2003). Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation. NEJM
349: 2201-2210
[Abstract][Full Text]
Kanda, Y., Chiba, S., Hirai, H., Sakamaki, H., Iseki, T., Kodera, Y., Karasuno, T., Okamoto, S., Hirabayashi, N., Iwato, K., Maruta, A., Fujimori, Y., Furukawa, T., Mineishi, S., Matsuo, K., Hamajima, N., Imamura, M.
(2003). Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood
102: 1541-1547
[Abstract][Full Text]
Grewal, S. S., Barker, J. N., Davies, S. M., Wagner, J. E.
(2003). Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood
101: 4233-4244
[Full Text]
Shimazaki, C., Ochiai, N., Uchida, R., Okano, A., Fuchida, S.-i., Ashihara, E., Inaba, T., Fujita, N., Maruya, E., Nakagawa, M.
(2003). Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood
101: 3334-3336
[Abstract][Full Text]
Yang, Y.-G., Qi, J., Wang, M.-G., Sykes, M.
(2002). Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells. Blood
99: 4207-4215
[Abstract][Full Text]
Pennings, G., Schots, R., Liebaers, I.
(2002). Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling. Hum Reprod
17: 534-538
[Abstract][Full Text]
Ho, V. T., Soiffer, R. J.
(2001). The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood
98: 3192-3204
[Full Text]
Urbano-Ispizua, A., Rozman, C., Pimentel, P., Solano, C., de la Rubia, J., Brunet, S., Perez-Oteiza, J., Ferra, C., Zuazu, J., Caballero, D., Carvalhais, A., Diez, J. L., Espigado, I., Martinez, C., Campilho, F., Sanz, M. A., Sierra, J., Garcia-Conde, J., Montserrat, E.
(2001). The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings. Blood
97: 383-387
[Abstract][Full Text]
Davies, S. M., Kollman, C., Anasetti, C., Antin, J. H., Gajewski, J., Casper, J. T., Nademanee, A., Noreen, H., King, R., Confer, D., Kernan, N. A.
(2000). Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program. Blood
96: 4096-4102
[Abstract][Full Text]
Zhou, Y., Barnett, M. J., Rivers, J. K.
(2000). Clinical Significance of Skin Biopsies in the Diagnosis and Management of Graft-vs-Host Disease in Early Postallogeneic Bone Marrow Transplantation. Arch Dermatol
136: 717-721
[Abstract][Full Text]
Godder, K. T., Hazlett, L. J., Abhyankar, S. H., Chiang, K. Y., Christiansen, N. P., Bridges, K. D., Lee, C. G., Geier, S. S., Goon-Johnson, K. S., Gee, A. P., Pati, A. R., Parrish, R. S., Henslee-Downey, P. J.
(2000). Partially Mismatched Related-Donor Bone Marrow Transplantation for Pediatric Patients With Acute Leukemia: Younger Donors and Absence of Peripheral Blasts Improve Outcome. JCO
18: 1856-1866
[Abstract][Full Text]
McGlave, P. B., Shu, X. O., Wen, W., Anasetti, C., Nademanee, A., Champlin, R., Antin, J. H., Kernan, N. A., King, R., Weisdorf, D. J.
(2000). Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program. Blood
95: 2219-2225
[Abstract][Full Text]
Kantarjian, H., Melo, J. V., Tura, S., Giralt, S., Talpaz, M.
(2000). Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies. ASH Education Book
2000: 90-109
[Abstract][Full Text]
Tseng, L.-H., Lin, M.-T., Hansen, J. A., Gooley, T., Pei, J., Smith, A. G., Martin, E. G., Petersdorf, E. W., Martin, P. J.
(1999). Correlation Between Disparity for the Minor Histocompatibility Antigen HA-1 and the Development of Acute Graft-Versus-Host Disease After Allogeneic Marrow Transplantation. Blood
94: 2911-2914
[Abstract][Full Text]
Guinan, E. C., Boussiotis, V. A., Neuberg, D., Brennan, L. L., Hirano, N., Nadler, L. M., Gribben, J. G.
(1999). Transplantation of Anergic Histoincompatible Bone Marrow Allografts. NEJM
340: 1704-1714
[Abstract][Full Text]
Strasser, S. I., Sullivan, K. M., Myerson, D., Spurgeon, C. L., Storer, B., Schoch, H. G., Murakami, C. S., McDonald, G. B.
(1999). Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors. Blood
93: 3259-3266
[Abstract][Full Text]
Scott, I., O'Shea, J., Bunce, M., Tiercy, J.-M., Arguello, J. R., Firman, H., Goldman, J., Prentice, H. G., Little, A.-M., Madrigal, J. A.
(1998). Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow Donor Selection. Blood
92: 4864-4871
[Abstract][Full Text]
Greinix, H. T., Volc-Platzer, B., Rabitsch, W., Gmeinhart, B., Guevara-Pineda, C., Kalhs, P., Krutmann, J., Honigsmann, H., Ciovica, M., Knobler, R. M.
(1998). Successful Use of Extracorporeal Photochemotherapy in the Treatment of Severe Acute and Chronic Graft-Versus-Host Disease. Blood
92: 3098-3104
[Abstract][Full Text]
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y., Martelli, M. F., Felicini, R., Falcinelli, F., Carotti, A., Perruccio, K., Ballanti, S., Santucci, A., Gambelunghe, C.
(1998). Treatment of High-Risk Acute Leukemia with T-Cell-Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype. NEJM
339: 1186-1193
[Abstract][Full Text]
Drobyski, W. R., Majewski, D., Ozker, K., Hanson, G.
(1998). Ex Vivo Anti-CD3 Antibody-Activated Donor T Cells Have a Reduced Ability to Cause Lethal Murine Graft-Versus-Host Disease but Retain Their Ability to Facilitate Alloengraftment. J. Immunol.
161: 2610-2619
[Abstract][Full Text]
Morton, A. J., Gooley, T., Hansen, J. A., Appelbaum, F. R., Bruemmer, B., Bjerke, J. W., Clift, R., Martin, P. J., Petersdorf, E. W., Sanders, J. E., Storb, R., Sullivan, K. M., Woolfrey, A., Anasetti, C.
(1998). Association Between Pretransplant Interferon-alpha and Outcome After Unrelated Donor Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase. Blood
92: 394-401
[Abstract][Full Text]
Bernstein, S. H., Nademanee, A. P., Vose, J. M., Tricot, G., Fay, J. W., Negrin, R. S., DiPersio, J., Rondon, G., Champlin, R., Barnett, M. J., Cornetta, K., Herzig, G. P., Vaughan, W., Geils, G. Jr, Keating, A., Messner, H., Wolff, S. N., Miller, K. B., Linker, C., Cairo, M., Hellmann, S., Ashby, M., Stryker, S., Nash, R. A.
(1998). A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation. Blood
91: 3509-3517
[Abstract][Full Text]
Hansen, J. A., Gooley, T. A., Martin, P. J., Appelbaum, F., Chauncey, T. R., Clift, R. A., Petersdorf, E. W., Radich, J., Sanders, J. E., Storb, R. F., Sullivan, K. M., Anasetti, C.
(1998). Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia. NEJM
338: 962-968
[Abstract][Full Text]
Beelen, D. W., Ottinger, H. D., Elmaagacli, A., Scheulen, B., Basu, O., Kremens, B., Havers, W., Grosse-Wilde, H., Schaefer, U. W.
(1997). Transplantation of Filgrastim-Mobilized Peripheral Blood Stem Cells From HLA-Identical Sibling or Alternative Family Donors in Patients With Hematologic Malignancies: A Prospective Comparison on Clinical Outcome, Immune Reconstitution, and Hematopoietic Chimerism. Blood
90: 4725-4735
[Abstract][Full Text]
Yang, Y.-G., Sergio, J. J., Pearson, D. A., Szot, G. L., Shimizu, A., Sykes, M.
(1997). Interleukin-12 Preserves the Graft-Versus-Leukemia Effect of Allogeneic CD8 T Cells While Inhibiting CD4-Dependent Graft-Versus-Host Disease in Mice. Blood
90: 4651-4660
[Abstract][Full Text]
Torok-Storb, B., Boeckh, M., Hoy, C., Leisenring, W., Myerson, D., Gooley, T.
(1997). Association of Specific Cytomegalovirus Genotypes With Death From Myelosuppression After Marrow Transplantation. Blood
90: 2097-2102
[Abstract][Full Text]
Henslee-Downey, P. J., Abhyankar, S. H., Parrish, R. S., Pati, A. R., Godder, K. T., Neglia, W. J., Goon-Johnson, K. S., Geier, S. S., Lee, C. G., Gee, A. P.
(1997). Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow Transplant. Blood
89: 3864-3872
[Abstract][Full Text]
Koch, U., Korngold, R.
(1997). A Synthetic CD4-CDR3 Peptide Analog Enhances Bone Marrow Engraftment Across Major Histocompatibility Barriers. Blood
89: 2880-2890
[Abstract][Full Text]
Petersdorf, E. W., Longton, G. M., Anasetti, C., Mickelson, E. M., McKinney, S. K., Smith, A. G., Martin, P. J., Hansen, J. A.
(1997). Association of HLA-C Disparity With Graft Failure After Marrow Transplantation From Unrelated Donors. Blood
89: 1818-1823
[Abstract][Full Text]
Miller, K. B., Graeme-Cook, F. M.
(1996). Case 19-1996- Multisystem failure in a 33-year-old man after bone marrow transplantation. NEJM
334: 1655-1662
[Full Text]
Quaglini, S., Bellazzi, R., Locatelli, F., Stefanelli, M., Salvaneschi, C.
(1994). An Influence Diagram for Assessing GVHD Prophylaxis after Bone Marrow Transplantation in Children. Med Decis Making
14: 223-235
[Abstract]
Armitage, J. O.
(1994). Bone Marrow Transplantation. NEJM
330: 827-838
[Full Text]
Kernan, N. A., Bartsch, G., Ash, R. C., Beatty, P. G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J. A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H. A., Phillips, G. L., Sanders, J., Stroncek, D., Thomas, E. D., Blume, K. G.
(1993). Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program. NEJM
328: 593-602
[Abstract][Full Text]
Bortin, M. M., Horowitz, M. M., Rimm, A. A.
(1992). Increasing Utilization of Allogeneic Bone Marrow Transplantation: Results of the 1988-1990 Survey. ANN INTERN MED
116: 505-512
[Abstract]
(1990). Questions and Answers. JAMA
264: 3208-3211
van Rood, J., Claas, F.
(1990). The influence of allogeneic cells on the human T and B cell repertoire. Science
248: 1388-1393
[Abstract]
Champlin, R. E., Kastenberg, W. E., Gale, R. P.
(1988). Radiation Accidents and Nuclear Energy: Medical Consequences and Therapy. ANN INTERN MED
109: 730-744
[Abstract]
PIRSCH, J. D., MAKI, D. G.
(1986). Infectious Complications in Adults with Bone Marrow Transplantation and T-Cell Depletion of Donor Marrow: Increased Susceptibility to Fungal Infections. ANN INTERN MED
104: 619-631
[Abstract]
Thomas, E.D.
(1986). Marrow Transplantation and Gene Transfer as Therapy for Hematopoietic Diseases. Cold Spring Harb Symp Quant Biol
51: 1009-1012
[Abstract]
